WO1998054213A3 - Neurotrophic factor receptors - Google Patents
Neurotrophic factor receptors Download PDFInfo
- Publication number
- WO1998054213A3 WO1998054213A3 PCT/US1998/008486 US9808486W WO9854213A3 WO 1998054213 A3 WO1998054213 A3 WO 1998054213A3 US 9808486 W US9808486 W US 9808486W WO 9854213 A3 WO9854213 A3 WO 9854213A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gdnf
- gdnfr
- neurotrophic factor
- found
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002291608A CA2291608C (en) | 1997-05-30 | 1998-04-27 | Neurotrophic factor receptors |
EP98918805A EP0983354A2 (en) | 1997-05-30 | 1998-04-27 | Neurotrophic factor receptors |
AU71659/98A AU7165998A (en) | 1997-05-30 | 1998-04-27 | Neurotrophic factor receptors |
JP50067499A JP2002505576A (en) | 1997-05-30 | 1998-04-27 | Neurotrophic factor receptor |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/866,354 US7138251B1 (en) | 1996-04-22 | 1997-05-30 | Polynucleotides encoding a neurotrophic factor receptor |
US08/866,354 | 1997-05-30 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO1998054213A2 WO1998054213A2 (en) | 1998-12-03 |
WO1998054213A3 true WO1998054213A3 (en) | 1999-01-07 |
WO1998054213B1 WO1998054213B1 (en) | 1999-02-18 |
Family
ID=25347430
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1998/008486 WO1998054213A2 (en) | 1997-05-30 | 1998-04-27 | Neurotrophic factor receptors |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0983354A2 (en) |
JP (1) | JP2002505576A (en) |
AU (1) | AU7165998A (en) |
CA (1) | CA2291608C (en) |
WO (1) | WO1998054213A2 (en) |
ZA (1) | ZA984404B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6696259B1 (en) | 1995-11-13 | 2004-02-24 | Licentia Ltd. | Assays using glial cell line-derived neurotrophic factor receptors |
US6677135B1 (en) | 1996-05-08 | 2004-01-13 | Biogen, Inc. | Ret ligand (RetL) for stimulating neutral and renal growth |
AU741208B2 (en) * | 1997-05-22 | 2001-11-22 | Urmas Arumae | Glial cell line-derived neurotrophic factor receptors |
US7026138B1 (en) | 1998-03-23 | 2006-04-11 | Genentech, Inc. | Polynucleotides encoding GFRα3 |
NZ506748A (en) * | 1998-03-23 | 2002-10-25 | Genentech Inc | Nucleic acids encoding a GFR alpha 3 polypeptide; host cell and vectors for production of the GRF alpha 3 protein and an assay for detecting GRFalpha 3 production |
DE19816186A1 (en) * | 1998-04-14 | 1999-10-21 | Univ Muenchen L Maximilians | GDNF-encoding DNA, parts thereof and GDNF variants |
EP3538560A4 (en) | 2016-11-10 | 2020-06-17 | Keros Therapeutics, Inc. | Gdnf fusion polypeptides and methods of use thereof |
KR20220079857A (en) * | 2019-09-13 | 2022-06-14 | 루트거스, 더 스테이트 유니버시티 오브 뉴 저지 | AAV-compatible laminin-linker polymeric protein |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0444561A2 (en) * | 1990-02-26 | 1991-09-04 | Roche Diagnostics GmbH | Method for the immunological determination of ligands |
WO1995005452A2 (en) * | 1993-08-12 | 1995-02-23 | Cytotherapeutics, Inc. | Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules |
WO1997040152A1 (en) * | 1996-04-22 | 1997-10-30 | Amgen Inc. | Glial cell line-derived neurotrophic factor receptor |
WO1997044356A2 (en) * | 1996-05-08 | 1997-11-27 | Biogen, Inc. | RET LIGAND (RetL) FOR STIMULATING NEURAL AND RENAL GROWTH |
EP0846764A2 (en) * | 1996-11-27 | 1998-06-10 | Smithkline Beecham Plc | Glial cell line-derived neurotrophic factor alpha receptor family |
WO1998036072A1 (en) * | 1997-02-18 | 1998-08-20 | Genentech, Inc. | Neurturin receptor |
-
1998
- 1998-04-27 CA CA002291608A patent/CA2291608C/en not_active Expired - Lifetime
- 1998-04-27 EP EP98918805A patent/EP0983354A2/en not_active Withdrawn
- 1998-04-27 AU AU71659/98A patent/AU7165998A/en not_active Abandoned
- 1998-04-27 WO PCT/US1998/008486 patent/WO1998054213A2/en active Application Filing
- 1998-04-27 JP JP50067499A patent/JP2002505576A/en not_active Ceased
- 1998-05-25 ZA ZA984404A patent/ZA984404B/en unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0444561A2 (en) * | 1990-02-26 | 1991-09-04 | Roche Diagnostics GmbH | Method for the immunological determination of ligands |
WO1995005452A2 (en) * | 1993-08-12 | 1995-02-23 | Cytotherapeutics, Inc. | Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules |
WO1997040152A1 (en) * | 1996-04-22 | 1997-10-30 | Amgen Inc. | Glial cell line-derived neurotrophic factor receptor |
WO1997044356A2 (en) * | 1996-05-08 | 1997-11-27 | Biogen, Inc. | RET LIGAND (RetL) FOR STIMULATING NEURAL AND RENAL GROWTH |
EP0846764A2 (en) * | 1996-11-27 | 1998-06-10 | Smithkline Beecham Plc | Glial cell line-derived neurotrophic factor alpha receptor family |
WO1998036072A1 (en) * | 1997-02-18 | 1998-08-20 | Genentech, Inc. | Neurturin receptor |
Non-Patent Citations (6)
Title |
---|
BALOH, R. H. ET AL: "TRNR2, A NOVEL RECEPTOR THAT MEDIATES NEURTURIN AND GDNF SIGNALING THROUGH RET", NEURON, vol. 18, May 1997 (1997-05-01), pages 793 - 802, XP002065821 * |
DATABASE EMBL - EMROD 9 February 1997 (1997-02-09), WATABE, K.: "Mouse mRNA for GDNF receptor alpha, complete cds.", XP002073411 * |
DATABASE EMBL - R53U072 2 June 1997 (1997-06-02), BALOH, R.H. ET AL.: "Homo sapiens GDNF family receptor alpha 2 (GFRalpha2) mRNA, complete cds." * |
ECONOMIDES, A.N. ET AL.: "Designer cytokines: targeting actions to cells of choice", SCIENCE, vol. 270, 24 November 1995 (1995-11-24), pages 1351 - 3, XP002072653 * |
JING S ET AL: "GDNF-INDUCED ACTIVATION OF THE RET PROTEIN TYROSINE KINASE IS MEDIATED BY GDNFR-ALPHA, A NOVEL RECEPTOR FOR GDNF", CELL, vol. 85, 28 June 1996 (1996-06-28), pages 1113 - 1124, XP002036435 * |
SANICOLA M ET AL: "GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR-DEPENDENT RET ACTIVATION CAN BE MEDIATED BY TWO DIFFERENT CELL-SURFACE ACCESSORY PROTEINS", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, vol. 94, no. 12, 10 June 1997 (1997-06-10), pages 6238 - 6243, XP002065823 * |
Also Published As
Publication number | Publication date |
---|---|
CA2291608C (en) | 2004-04-13 |
EP0983354A2 (en) | 2000-03-08 |
AU7165998A (en) | 1998-12-30 |
ZA984404B (en) | 1998-12-01 |
WO1998054213A2 (en) | 1998-12-03 |
JP2002505576A (en) | 2002-02-19 |
CA2291608A1 (en) | 1998-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ332256A (en) | Glial cell line-derived neurotrophic factor (GDNF) receptors and nucleic and amino acid sequences encoding them | |
Goulding et al. | Role of H5 domain in determining pore diameter and ion permeation through cyclic nucleotide-gated channels | |
WO1997033995A3 (en) | Extracellular matrix signalling molecules | |
WO1998054213A3 (en) | Neurotrophic factor receptors | |
WO2003004992A3 (en) | Mammalian sweet and amino acid heterodimeric taste receptors | |
IL195337A0 (en) | Cyr61 compositions and methods | |
WO1998027113A3 (en) | Melanocortin derivatives for specific binding of melanocortin receptor 3, 4 or 5 | |
WO2003057725A3 (en) | Cell-permeable peptide inhibitors of the jnk signal transduction pathway | |
WO2000034475A3 (en) | Grnf4, a gdnf-related neurotrophic factor | |
WO1997032020A3 (en) | Shc proteins | |
IL138593A (en) | Glial factor receptor ??3 (gfr??3) polypeptide, nucleic acid encoding the same, process for preparation thereof, vectors, host cells, antibodies, chimeric molecules and use of such gfr??3 | |
WO1998054213B1 (en) | Neurotrophic factor receptors | |
CA2487779A1 (en) | P53 binding t cell receptor molecules and uses thereof | |
WO2002066636A3 (en) | T cell receptor variants expressed in mesenchymal cells and uses thereof | |
Woodman | ESCRT-III on endosomes: new functions, new activation pathway | |
WO2002042458A3 (en) | G protein coupled receptors | |
WO2001073029A3 (en) | Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof | |
CA2227554A1 (en) | Nucleic sequences coding for melatonin receptors, and uses thereof | |
WO1999021994A3 (en) | Human vesicle membrane protein-like proteins | |
WO2001087932A3 (en) | Seven transmembrane proteins and polynucleotides encoding the same | |
WO2001032871A3 (en) | Follistatin-related protein zfsta4 | |
WO1992016623A3 (en) | Receptors for bombesin-like peptides | |
WO1999000408A3 (en) | Human transmembrane protein from the transmembrane 4 superfamily | |
Wang et al. | Action of peptidases in brain synaptic membranes on the NH2-terminus of adrenocorticotropin using ACTH-(1–16)-NH2 as a model substrate | |
WO2002003071A3 (en) | Modulators of trk protein activity, compositions and uses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/1999/010806 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1998918805 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2291608 Country of ref document: CA Ref country code: CA Ref document number: 2291608 Kind code of ref document: A Format of ref document f/p: F |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 1999 500674 Kind code of ref document: A Format of ref document f/p: F |
|
WWP | Wipo information: published in national office |
Ref document number: 1998918805 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |